DECEASED DONOR KIDNEY TRANSPLANT
Clinical trials for DECEASED DONOR KIDNEY TRANSPLANT explained in plain language.
Never miss a new study
Get alerted when new DECEASED DONOR KIDNEY TRANSPLANT trials appear
Sign up with your email to follow new studies for DECEASED DONOR KIDNEY TRANSPLANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to wake up transplanted kidneys faster
Disease control TerminatedThis study tests a drug called pegcetacoplan in 320 adults who are getting a kidney transplant from a deceased donor and are at high risk for delayed graft function (when the kidney takes a while to start working). The goal is to see if the drug helps the kidney work sooner and r…
Matched conditions: DECEASED DONOR KIDNEY TRANSPLANT
Phase: PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Massive study aims to stop wasting donated kidneys worldwide
Knowledge-focused ENROLLING_BY_INVITATIONThis study tracks 300,000 donated kidneys from 2010 to 2025 across many countries. Researchers want to see why some kidneys are discarded and how to use them better. The goal is to help more people get transplants and reduce organ waste.
Matched conditions: DECEASED DONOR KIDNEY TRANSPLANT
Sponsor: Paris Translational Research Center for Organ Transplantation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC